Page results
-
UCLH provides an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia.
-
We provide an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia.
-
UCLH is a centre of excellence in the management of patients with acute and chronic leukaemia. We provide an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia.
-
UCLH is a centre of excellence in the management of patients with acute and chronic leukaemia.
-
The Preterm Birth Clinic is one of a few UK specialist antenatal services that are designed specifically for the needs of pregnant women at risk of premature labour.
-
The bone marrow transplant and haematopoietic stem cell transplant service at UCLH is the largest in Europe and provides a full range of transplant services.
-
UCLH is a designated Haemophilia Centre providing a 24/7 service for patients, including those needing treatment with blood products and clotting factor medications.
-
Thalassaemia is a group of inherited blood conditions where the part of the blood known as haemoglobin is abnormal.
-
This clinic is for asymptomatic travellers (individuals with no current symptoms) who have travelled to a tropical destination and are worried about certain infections.
-
Preparations for the festive season are in full swing in the UCLH Charity fundraising team.
File results
-
FOI/2023/0493 - Treatments for various diseases
-
FOI/2023/0497 - List of all laboratories within Pathology
-
FOI/2023/0499 - Treatments for non-small cell lung cancer
-
FOI/2023/0500 - Treatment of urothelial and colorectal cancer
-
FOI/2023/0501 - Central Airway Tumour Management/ Endobronchial Valves for treatment of Emphysema
-
FOI/2023/0505 - Telecommunications infrastructure contract
-
FOI/2023/0507 - Mental health patient suicides
-
FOI/2023/0565 - Rare diseases - diagnosis/ treatment for Fabry/ Gaucher/ Pompe
-
FOI/2023/0569 - Treatment for Ruxolitinib
-
FOI/2023/0566 - Structure chart for IM &T, Business Intelligence, Informatics